NCT07165132 2026-04-13Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.RayzeBio, Inc.Phase 1 Recruiting104 enrolled
NCT03093116 2026-04-03TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 5 FDA
NCT07314164 2026-04-01Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior TreatmentIpsenRecruiting150 enrolled